| For: |
Seth D, Duly A, Kuo PC, McCaughan GW, Haber PS. Osteopontin is an important mediator of alcoholic liver disease |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i36/13088.htm |
| Number | Citing Articles |
| 1 |
Lingman Ma, Xuanyi Li, Zhaoshi Bai, Xinhao Lin, Kejiang Lin. AdipoRs- a potential therapeutic target for fibrotic disorders. Expert Opinion on Therapeutic Targets 2019; 23(2) doi: 10.1080/14728222.2019.1559823
|
| 2 |
Junran Yang, Yufei Yao, Zhenhua Zhou. Osteopontin: a central hub in the pathogenesis and therapeutic intervention of liver disease. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2025.2596538
|
| 3 |
. 2020; doi: 10.70675/b6c577cdzcaffz460az8214z9681de8f3941
|
| 4 |
Ling-Zu Kong, Nisansala Chandimali, Ying-Hao Han, Dong-Ho Lee, Ji-Su Kim, Sun-Uk Kim, Tae-Don Kim, Dong Kee Jeong, Hu-Nan Sun, Dong Sun Lee, Taeho Kwon. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. International Journal of Molecular Sciences 2019; 20(11) doi: 10.3390/ijms20112712
|
| 5 |
Natalia A Osna, Murali Ganesan, Devanshi Seth, Todd A Wyatt, Srivatsan Kidambi, Kusum K Kharbanda. Second hits exacerbate alcohol-related organ damage: an update. Alcohol and Alcoholism 2021; 56(1) doi: 10.1093/alcalc/agaa085
|
| 6 |
Moritz Peiseler, Frank Tacke. Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma. Cancers 2021; 13(4) doi: 10.3390/cancers13040730
|
| 7 |
Akitoshi Sano, Qianqian Guo, Samar H. Ibrahim. VCAM-1 and Osteopontin Link Hemodynamic Alteration to Fibrosis in Portal Hypertension. Cellular and Molecular Gastroenterology and Hepatology 2026; 20(6) doi: 10.1016/j.jcmgh.2025.101663
|
| 8 |
Glenn S Gerhard, Christophe Legendre, Christopher D Still, Xin Chu, Anthony Petrick, Johanna K DiStefano. Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes. Journal of the Endocrine Society 2018; 2(7) doi: 10.1210/js.2018-00122
|
| 9 |
Zhi Zhong, John J. Lemasters. A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease. Alcoholism: Clinical and Experimental Research 2018; 42(11) doi: 10.1111/acer.13877
|
| 10 |
Gaiping Wang, Peipei Chu, Meng Chen, Liya Cheng, Congcong Zhao, Shasha Chen, Xiaofang Li, Ganggang Yang, Cuifang Chang.
Osteopontin promotes rat hepatocyte proliferation both
in vitro
and
in vivo
. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1) doi: 10.1080/21691401.2019.1666862
|
| 11 |
. 2014; doi: 10.70675/bea4ea3bzea9dz415cz8833z4550cabe679b
|
| 12 |
Liz Simon, Flavia M. Souza-Smith, Patricia E. Molina. Alcohol-Associated Tissue Injury: Current Views on Pathophysiological Mechanisms. Annual Review of Physiology 2022; 84(1) doi: 10.1146/annurev-physiol-060821-014008
|
| 13 |
Zohreh Khajehahmadi, Sina Mohagheghi, Saman Nikeghbalian, Bita Geramizadeh, Iraj Khodadadi, Jamshid Karimi, Heidar Tavilani. Liver stiffness correlates with serum osteopontin and TAZ expression in human liver cirrhosis. Annals of the New York Academy of Sciences 2020; 1465(1) doi: 10.1111/nyas.14259
|
| 14 |
Arpita Suri, Naveen Singh, Sanjiv Kumar Bansal. A Study on the Serum γ-Glutamyltranspeptidase and Plasma Osteopontin in Alcoholic Liver Disease. Journal of Laboratory Physicians 2022; 14(02) doi: 10.1055/s-0041-1729479
|
| 15 |
Delfin Gerard Buyco, Jasmin Martin, Sookyoung Jeon, Royce Hooks, Chelsea Lin, Rotonya Carr. Experimental models of metabolic and alcoholic fatty liver disease. World Journal of Gastroenterology 2021; 27(1): 1-18 doi: 10.3748/wjg.v27.i1.1
|
| 16 |
Hong Lu. Inflammatory liver diseases and susceptibility to sepsis. Clinical Science 2024; 138(7) doi: 10.1042/CS20230522
|
| 17 |
Pramod Patidar, Nik Hirani, Shreya Bharti, Mirza S Baig. Key regulators of hepatic stellate cell activation in alcohol liver Disease: A comprehensive review. International Immunopharmacology 2024; 141 doi: 10.1016/j.intimp.2024.112938
|
| 18 |
Richard J.W. Wilkin, Patricia F. Lalor, Richard Parker, Philip N. Newsome. Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease. The American Journal of Pathology 2016; 186(4) doi: 10.1016/j.ajpath.2015.12.003
|
| 19 |
Tomoya Iida, Kohei Wagatsuma, Daisuke Hirayama, Hiroshi Nakase. Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?. International Journal of Molecular Sciences 2017; 19(1) doi: 10.3390/ijms19010007
|
| 20 |
Claire E. McQuitty, Roger Williams, Shilpa Chokshi, Luca Urbani. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.574276
|
| 21 |
Martin Guilliams, Charlotte L. Scott. Liver macrophages in health and disease. Immunity 2022; 55(9) doi: 10.1016/j.immuni.2022.08.002
|
| 22 |
|
| 23 |
Aniela Golub, Michal Ordak, Tadeusz Nasierowski, Magdalena Bujalska-Zadrozny. Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances. International Journal of Molecular Sciences 2023; 24(11) doi: 10.3390/ijms24119413
|
| 24 |
Yukun Li, Miaomiao Wei, Qi Yuan, Yu Liu, Tian Tian, Lingling Hou, Jinhua Zhang. MyD88 in hepatic stellate cells promotes the development of alcoholic fatty liver via the AKT pathway. Journal of Molecular Medicine 2022; 100(7) doi: 10.1007/s00109-022-02196-1
|
| 25 |
Lauren G. Poole, Gavin E. Arteel. Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury. BioMed Research International 2016; 2016 doi: 10.1155/2016/3162670
|
| 26 |
Ming-Jiang Xu, Zhou Zhou, Richard Parker, Bin Gao. Targeting inflammation for the treatment of alcoholic liver disease. Pharmacology & Therapeutics 2017; 180 doi: 10.1016/j.pharmthera.2017.06.007
|
| 27 |
Gaiping Wang, Xiaofang Li, Shasha Chen, Weiming Zhao, Jing Yang, Cuifang Chang, Cunshuan Xu. Expression profiles uncover the correlation of OPN signaling pathways with rat liver regeneration at cellular level. Cell Biology International 2015; 39(11) doi: 10.1002/cbin.10523
|
| 28 |
Reem Ghazali, Vinood B. Patel. Molecular Aspects of Alcohol and Nutrition. 2016; doi: 10.1016/B978-0-12-800773-0.00002-1
|
| 29 |
Radan Bruha, Marie Jachymova, Jaromir Petrtyl, Karel Dvorak, Martin Lenicek, Petr Urbanek, Tomislav Svestka, Libor Vitek. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. World Journal of Gastroenterology 2016; 22(12): 3441-3450 doi: 10.3748/wjg.v22.i12.3441
|
| 30 |
Yeping Yu, Xinyi Mao, Jieying Wang, Mo Chen, Fang Wang, Xiaoni Kong, Hualian Hang. SPP1 as a risk factor for patients with acute on chronic liver failure undergoing liver transplantation. International Immunopharmacology 2023; 120 doi: 10.1016/j.intimp.2023.110355
|
| 31 |
Sebastian Rasch, Irena Valantiene, Artautas Mickevicius, Sebastian Beer, Jonas Rosendahl, Richard M. Charnley, Stuart M. Robinson. Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype?. Pancreatology 2016; 16(5) doi: 10.1016/j.pan.2016.08.004
|
| 32 |
Christine E. Dolin, Toshifumi Sato, Michael L. Merchant, Gavin E. Arteel. Extracellular Matrix Omics. Biology of Extracellular Matrix 2020; 7 doi: 10.1007/978-3-030-58330-9_3
|
| 33 |
Jan Petrasek, Gyongyi Szabo. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; doi: 10.1007/978-3-319-20538-0_15
|
| 34 |
Veruska Cintia Alexandrino de Souza, Thiago Almeida Pereira, Valéria Wanderley Teixeira, Helotonio Carvalho, Maria Carolina Accioly Brelaz de Castro, Carolline Guimarães D’assunção, Andréia Ferreira de Barros, Camila Lima Carvalho, Virgínia Maria Barros de Lorena, Vláudia Maria Assis Costa, Álvaro Aguiar Coelho Teixeira, Regina Celia Bressan Queiroz Figueiredo, Sheilla Andrade de Oliveira. Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. World Journal of Gastroenterology 2017; 23(28): 5146-5157 doi: 10.3748/wjg.v23.i28.5146
|
| 35 |
K. M. Moyes, P. Sørensen, M. Bionaz, Ramona Natacha PENA i SUBIRÀ. The Impact of Intramammary Escherichia coli Challenge on Liver and Mammary Transcriptome and Cross-Talk in Dairy Cows during Early Lactation Using RNAseq. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0157480
|
| 36 |
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma, Sukhbir Singh. Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development. Current Drug Discovery Technologies 2021; 18(3) doi: 10.2174/1570163817666200121143959
|
| 37 |
S.R. Rittling, R. Singh. Osteopontin in Immune-mediated Diseases. Journal of Dental Research 2015; 94(12) doi: 10.1177/0022034515605270
|
| 38 |
Lakshmi Kuttippurathu, Egle Juskeviciute, Rachael P Dippold, Jan B. Hoek, Rajanikanth Vadigepalli. A novel comparative pattern analysis approach identifies chronic alcohol mediated dysregulation of transcriptomic dynamics during liver regeneration. BMC Genomics 2016; 17(1) doi: 10.1186/s12864-016-2492-x
|
| 39 |
Tingting Zhou, Musunuru Kiran, Kathy O Lui, Qiurong Ding. Decoding liver fibrogenesis with single-cell technologies. Life Medicine 2022; 1(3) doi: 10.1093/lifemedi/lnac040
|
| 40 |
Gavin E. Arteel, David W. Crabb. Alcoholic and Non-Alcoholic Fatty Liver Disease. 2016; doi: 10.1007/978-3-319-20538-0_3
|
| 41 |
V. Rosato, L. Abenavoli, A. Federico, M. Masarone, M. Persico. Pharmacotherapy of alcoholic liver disease in clinical practice. International Journal of Clinical Practice 2016; 70(2) doi: 10.1111/ijcp.12764
|
| 42 |
Mack C. Mitchell, Gyongyi Szabo. Schiff's Diseases of the Liver. 2017; doi: 10.1002/9781119251316.ch26
|
| 43 |
Hereward J. Wimborne, Kenji Takemoto, Patrick M. Woster, Don C. Rockey, John J. Lemasters, Zhi Zhong. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice. Free Radical Biology and Medicine 2019; 145 doi: 10.1016/j.freeradbiomed.2019.09.026
|
| 44 |
Marco A. Briones-Orta, Blanca Delgado-Coello, Roxana Gutiérrez-Vidal, Marcela Sosa-Garrocho, Marina Macías-Silva, Jaime Mas-Oliva. Quantitative Expression of Key Cancer Markers in the AS-30D Hepatocarcinoma Model. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.670292
|
| 45 |
Anneleen Remmerie, Liesbet Martens, Tinne Thoné, Angela Castoldi, Ruth Seurinck, Benjamin Pavie, Joris Roels, Bavo Vanneste, Sofie De Prijck, Mathias Vanhockerhout, Mushida Binte Abdul Latib, Lindsey Devisscher, Anne Hoorens, Johnny Bonnardel, Niels Vandamme, Anna Kremer, Peter Borghgraef, Hans Van Vlierberghe, Saskia Lippens, Edward Pearce, Yvan Saeys, Charlotte L. Scott. Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver. Immunity 2020; 53(3) doi: 10.1016/j.immuni.2020.08.004
|
| 46 |
Gavin E. Arteel. Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype. Seminars in Liver Disease 2024; 44(03) doi: 10.1055/a-2404-7973
|
| 47 |
Divya Ramnath, Katharine M. Irvine, Samuel W. Lukowski, Leigh U. Horsfall, Zhixuan Loh, Andrew D. Clouston, Preya J. Patel, Kevin J. Fagan, Abishek Iyer, Guy Lampe, Jennifer L. Stow, Kate Schroder, David P. Fairlie, Joseph E. Powell, Elizabeth E. Powell, Matthew J. Sweet. Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight 2018; 3(14) doi: 10.1172/jci.insight.120274
|
| 48 |
Natalia A. Osna, Karuna Rasineni, Murali Ganesan, Terrence M. Donohue, Kusum K. Kharbanda. Pathogenesis of Alcohol-Associated Liver Disease. Journal of Clinical and Experimental Hepatology 2022; 12(6) doi: 10.1016/j.jceh.2022.05.004
|